Diagnostic of Chronic Thrombocytopenia
NCT04071496 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 158
Last updated 2019-08-28
Summary
The objective of this study is to provide simple and relevant clinical and biological elements to distinguish a possible Congenital Thrombocytopenia from a Chronic Idiopathic Thrombocytopenic Purpura .
Conditions
- Congenital Thrombocytopenia
- Chronic Idiopathic Thrombocytopenic Purpura
Interventions
- OTHER
-
Blood samples
1 dry tube of 5 ml, 3 citrated tubes of 5 ml, 1 tube citrate dextrose acid of 7 ml
Sponsors & Collaborators
-
University Hospital, Bordeaux
lead OTHER
Principal Investigators
-
Paquita NURDEN, Dr · University Hospital, Bordeaux
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-11-25
- Primary Completion
- 2012-03-12
- Completion
- 2012-03-12
More Related Trials
-
An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
NCT00005570 ·Status: COMPLETED
-
Assessment of Quality of Life of Children With Chronic Idiopathic Thrombocytopenic Purpura (Kid's ITP Tools)
NCT03123497 ·Status: UNKNOWN
-
Immune Thrombocytopenia (ITP) Immune-Genetic Assessment
NCT01196884 ·Status: UNKNOWN
-
Study of Platelets Sialylation by Flow Cytometry for the Differential Diagnosis of ICT
NCT03421392 ·Status: COMPLETED
-
Bleeding In Thrombocytopenia Explained
NCT03505086 ·Status: RECRUITING
-
Research of Predictive Factors to Immune Thrombopenic Purpura
NCT01648556 ·Status: COMPLETED ·Phase: NA
-
Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis
NCT04800458 ·Status: RECRUITING ·Phase: NA
-
Ultrasound to Detect Splenomegally in Patients With Isolated Thrombocytopenia
NCT07182760 ·Status: NOT_YET_RECRUITING
-
Risk Factors for Thrombosis in Immune Thrombocytopenia
NCT03820960 ·Status: COMPLETED
-
Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS)
NCT03469661 ·Status: COMPLETED
-
Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)
NCT06107582 ·Status: RECRUITING
-
A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients
NCT03187652 ·Status: RECRUITING
-
Research for Plasma Biomarkers Associated With Fatigue in Thrombocytopenic Patients
NCT06979765 ·Status: RECRUITING ·Phase: NA
-
Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
NCT00331357 ·Status: UNKNOWN
-
National Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia.
NCT04070612 ·Status: COMPLETED
-
Safety of Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP
NCT05846529 ·Status: UNKNOWN
-
Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)
NCT06665308 ·Status: COMPLETED
-
The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.
NCT01101295 ·Status: UNKNOWN
-
Eltrombopag in Chronic ITP
NCT04102033 ·Status: UNKNOWN ·Phase: PHASE4
-
French Adult Primary Immune Thrombocytopenia
NCT03429660 ·Status: UNKNOWN
-
Study of Immune Thrombocytopenia Pathogenesis:
NCT02042560 ·Status: COMPLETED
-
The Outcome of the Thrombopoietin Receptor Agonists in Pediatric Patient With Persistent or Chronic ITP Unresonsive to Steroids
NCT06568913 ·Status: RECRUITING ·Phase: NA
-
Study of Constitutional Platelet Disease
NCT04419987 ·Status: UNKNOWN ·Phase: NA
-
A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
NCT01440361 ·Status: WITHDRAWN ·Phase: PHASE2
-
Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia
NCT02298075 ·Status: COMPLETED